- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有1家主力机构披露2025-12-31报告期持股数据，持仓量总计5.92万股，占流通A股0.01%
- 波段诊断：
-
技术面诊股
诊断结果：4.5技术面打败了30%的股票
技术面评分前10的股票
近期的平均成本为6.25元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为6.25元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.25","date":1773303215,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.03.13","stock":"0.00","trade":"-0.27","ind":"-0.65"},{"date":"2026.03.12","stock":"-0.32","trade":"-0.77","ind":"-0.63"},{"date":"2026.03.11","stock":"-0.95","trade":"-0.78","ind":"0.78"},{"date":"2026.03.10","stock":"2.44","trade":"2.53","ind":"2.04"},{"date":"2026.03.09","stock":"-0.65","trade":"-0.71","ind":"-0.74"},{"date":"2026.03.06","stock":"2.14","trade":"3.05","ind":"0.59"},{"date":"2026.03.05","stock":"0.66","trade":"0.79","ind":"1.23"},{"date":"2026.03.04","stock":"-0.17","trade":"-0.84","ind":"-0.75"},{"date":"2026.03.03","stock":"-2.11","trade":"-2.99","ind":"-3.07"},{"date":"2026.03.02","stock":"-4.19","trade":"-2.61","ind":"-0.20"},{"date":"2026.02.27","stock":"0.31","trade":"0.28","ind":"-0.06"},{"date":"2026.02.26","stock":"-1.38","trade":"-0.72","ind":"0.19"},{"date":"2026.02.25","stock":"0.77","trade":"1.27","ind":"1.29"},{"date":"2026.02.24","stock":"3.36","trade":"0.43","ind":"1.36"},{"date":"2026.02.13","stock":"-0.32","trade":"-0.55","ind":"-1.28"},{"date":"2026.02.12","stock":"-3.09","trade":"-0.47","ind":"0.86"},{"date":"2026.02.11","stock":"-1.67","trade":"-0.58","ind":"-0.35"},{"date":"2026.02.10","stock":"-0.45","trade":"0.30","ind":"0.02"},{"date":"2026.02.09","stock":"2.80","trade":"0.78","ind":"2.17"},{"date":"2026.02.06","stock":"1.58","trade":"0.22","ind":"-0.33"},{"date":"2026.02.05","stock":"-1.09","trade":"-0.38","ind":"-1.44"}]
博晖创新,深证成指,生物制品指数
压力支撑
该股压力位为6.24元，支撑位为6.18元。
[{"text":"\u538b\u529b\u4f4d","value":"6.24","date":1773331200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.18","date":1773331200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.5资金面打败了49%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月13日 20:30
| 机构今日流向(万元) | -1090.65 | 机构5日流向(万元) | -2053.88 |
| 机构10日流向(万元) | -7122.67 | 机构20日流向(万元) | -14729.16 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少498.48万股，其中基金数没有增加，主力净减仓21家，请投资者中长期谨慎为宜。
截止2025-12-31，共1家主力机构（基金1家），持仓量总计5.92万股，占流通A股0.01%
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有5.92万股
从主力名单中消失：22家 ，原持有504.4万股
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有5.92万股
从主力名单中消失：22家 ，原持有504.4万股
消息面诊股
诊断结果：5.1消息面打败了40%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 重磅！华经产业研究院发布《2025年中国人血白蛋白
2026-03-13 - 博晖创新邀您共聚 2026 CACLP｜智领精准诊
2026-03-10 - 中国疫苗行业协会血液制品分会2026年年会暨第一届
2026-03-04 - 上游材料价格持续走高推动终端提价！消费电子盈利拐点
2026-02-28 - 博晖创新：本次增值税征收方式调整后，将导致公司生物
2026-02-24 - WHX Labs Dubai 2026圆满收官｜博
2026-02-14 - 博晖创新主力资金持续净流入，3日共净流入2567.
2026-02-10 - 博晖创新：控股子公司签订增资补充协议
2026-02-05 - 多地检验组套目录发布：临床回归理性，检测进入“精准
2026-02-02 - 博晖创新：公司自研的尼帕病毒检测试剂盒已科研上市
2026-02-02
消息列表
| 一般消息 | 募资投向 | 公司出售资产 | 2026-02-05 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-02-05 |
| 一般消息 | 重大事项 | 关联交易 | 2026-02-05 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-23 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-01 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-14 |
| 一般消息 | 高管变动 | 因工作调整原因 | 2025-11-13 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-06-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：5.9行业面打败了87%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.03.13","price":"-0.65","value":"-0.27"},{"date":"2026.03.12","price":"-0.63","value":"-0.77"},{"date":"2026.03.11","price":"0.78","value":"-0.78"},{"date":"2026.03.10","price":"2.04","value":"2.53"},{"date":"2026.03.09","price":"-0.74","value":"-0.71"},{"date":"2026.03.06","price":"0.59","value":"3.05"},{"date":"2026.03.05","price":"1.23","value":"0.79"},{"date":"2026.03.04","price":"-0.75","value":"-0.84"},{"date":"2026.03.03","price":"-3.07","value":"-2.99"},{"date":"2026.03.02","price":"-0.20","value":"-2.61"},{"date":"2026.02.27","price":"-0.06","value":"0.28"},{"date":"2026.02.26","price":"0.19","value":"-0.72"},{"date":"2026.02.25","price":"1.29","value":"1.27"},{"date":"2026.02.24","price":"1.36","value":"0.43"},{"date":"2026.02.13","price":"-1.28","value":"-0.55"},{"date":"2026.02.12","price":"0.86","value":"-0.47"},{"date":"2026.02.11","price":"-0.35","value":"-0.58"},{"date":"2026.02.10","price":"0.02","value":"0.30"},{"date":"2026.02.09","price":"2.17","value":"0.78"},{"date":"2026.02.06","price":"-0.33","value":"0.22"},{"date":"2026.02.05","price":"-1.44","value":"-0.38"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万泽股份 | 35.87% | -1.62% | 5.7分 |
| 2 | 欧林生物 | 30.46% | 9.71% | 6.3分 |
| 3 | 荣昌生物 | 11.78% | 5.76% | 6.8分 |
| 4 | - | 9.96% | 7.37% | 分 |
| 5 | *ST四环 | 8.99% | 3.56% | 6.1分 |
| 6 | 诺诚健华 | 6.65% | 2.56% | 5.7分 |
| 8 | 康希诺 | 5.33% | -2.49% | 4.3分 |
| 10 | 西藏药业 | 3.89% | 3.25% | 6.1分 |
| 12 | 特宝生物 | 1.46% | -0.99% | 4.7分 |
| 14 | 通化东宝 | 0.33% | -0.22% | 5.1分 |
| 16 | 成大生物 | -0.81% | 1.66% | 5.2分 |
| 18 | 长春高新 | -1.26% | -1.02% | 4.0分 |
| 20 | 优宁维 | -1.50% | 0.12% | 5.2分 |
| 22 | 华兰生物 | -1.86% | -0.13% | 5.3分 |
| 24 | 科兴制药 | -2.80% | -2.22% | 5.3分 |
| 26 | 三生国健 | -3.20% | -2.29% | 5.8分 |
| 28 | 义翘神州 | -3.42% | -0.17% | 4.6分 |
| 30 | 安科生物 | -3.72% | -0.73% | 4.8分 |
| 32 | 近岸蛋白 | -4.18% | -1.71% | 4.0分 |
| 34 | 智翔金泰 | -4.37% | -0.52% | 4.7分 |
| 36 | 康弘药业 | -5.28% | -1.68% | 4.3分 |
| 38 | 甘李药业 | -6.01% | -2.40% | 5.3分 |
| 40 | 百奥泰 | -6.19% | -1.55% | 5.1分 |
| 42 | 博雅生物 | -7.13% | -1.70% | 4.2分 |
| 44 | 金迪克 | -7.24% | -2.98% | 3.9分 |
| 46 | 康辰药业 | -8.11% | -6.85% | 5.0分 |
| 48 | 赛伦生物 | -8.21% | -0.99% | 4.8分 |
| 50 | 康华生物 | -9.47% | -1.03% | 4.2分 |
| 52 | 康泰生物 | -9.68% | 0.07% | 3.7分 |
| 54 | 华兰疫苗 | -14.24% | 0.21% | 4.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 40/71 ， 44/71。
[{"date":"2025-09-30","value":"-2.47","vol":"-9.78"},{"date":"2025-06-30","value":"-1.36","vol":"-0.61"},{"date":"2025-03-31","value":"-0.29","vol":"0.46"},{"date":"2024-12-31","value":"0.67","vol":"-0.68"},{"date":"2024-09-30","value":"1.72","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.47 | -1.36 | -0.29 | 0.67 | 1.72 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"39.33","vol":"67.61"},{"date":"2025-06-30","value":"39.71","vol":"68.28"},{"date":"2025-03-31","value":"38.37","vol":"68.43"},{"date":"2024-12-31","value":"49.09","vol":"69.85"},{"date":"2024-09-30","value":"50.65","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
39.33 | 39.71 | 38.37 | 49.09 | 50.65 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 32/71 ， 50/71。
[{"date":"2025-09-30","value":"-2.68","vol":"45.25"},{"date":"2025-06-30","value":"-17.03","vol":"6902.04"},{"date":"2025-03-31","value":"-23.05","vol":"6125.27"},{"date":"2024-12-31","value":"-18.53","vol":"47.35"},{"date":"2024-09-30","value":"-19.85","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-2.68 | -17.03 | -23.05 | -18.53 | -19.85 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-241.73","vol":"44.80"},{"date":"2025-06-30","value":"-167.63","vol":"5.44"},{"date":"2025-03-31","value":"-120.41","vol":"-8.46"},{"date":"2024-12-31","value":"137.09","vol":"-9.81"},{"date":"2024-09-30","value":"67.77","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-241.73 | -167.63 | -120.41 | 137.09 | 67.77 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，两项指标的行业排名分别为 37/71 ， 45/71。
[{"date":"2025-09-30","value":"0.15","vol":"0.22"},{"date":"2025-06-30","value":"0.10","vol":"0.14"},{"date":"2025-03-31","value":"0.05","vol":"0.06"},{"date":"2024-12-31","value":"0.21","vol":"0.29"},{"date":"2024-09-30","value":"0.16","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.10 | 0.05 | 0.21 | 0.16 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.36","vol":"0.92"},{"date":"2025-06-30","value":"0.24","vol":"0.56"},{"date":"2025-03-31","value":"0.12","vol":"0.26"},{"date":"2024-12-31","value":"0.46","vol":"1.17"},{"date":"2024-09-30","value":"0.35","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.36 | 0.24 | 0.12 | 0.46 | 0.35 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-25.86","vol":"1.84"},{"date":"2025-06-30","value":"-10.44","vol":"-1377.61"},{"date":"2025-03-31","value":"-14.63","vol":"-46.99"},{"date":"2024-12-31","value":"-12.94","vol":"-11.33"},{"date":"2024-09-30","value":"-18.60","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -25.86 | -10.44 | -14.63 | -12.94 | -18.60 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.50","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.63","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.50 | - | 1.63 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 15/71 ， 20/71。
[{"date":"2025-09-30","value":"1.03","vol":"6.00"},{"date":"2025-06-30","value":"1.14","vol":"6.64"},{"date":"2025-03-31","value":"1.23","vol":"7.75"},{"date":"2024-12-31","value":"1.01","vol":"6.72"},{"date":"2024-09-30","value":"1.26","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.03 | 1.14 | 1.23 | 1.01 | 1.26 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.19","vol":"4.84"},{"date":"2025-06-30","value":"0.25","vol":"5.30"},{"date":"2025-03-31","value":"0.35","vol":"6.35"},{"date":"2024-12-31","value":"0.16","vol":"5.40"},{"date":"2024-09-30","value":"0.19","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.19 | 0.25 | 0.35 | 0.16 | 0.19 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 4/71 ， 6/71。
[{"date":"2025-09-30","value":"47.10","vol":"28.18"},{"date":"2025-06-30","value":"46.27","vol":"26.73"},{"date":"2025-03-31","value":"46.38","vol":"26.03"},{"date":"2024-12-31","value":"43.06","vol":"25.81"},{"date":"2024-09-30","value":"42.03","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
47.10 | 46.27 | 46.38 | 43.06 | 42.03 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.51","vol":"0.58"},{"date":"2025-06-30","value":"1.47","vol":"1.11"},{"date":"2025-03-31","value":"1.48","vol":"0.78"},{"date":"2024-12-31","value":"1.29","vol":"0.87"},{"date":"2024-09-30","value":"1.24","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.51 | 1.47 | 1.48 | 1.29 | 1.24 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"-3.22","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.78","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.09","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]